VeriMomaesculus hippocastanum fruit powder hamilelikte güvenli mi?
No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
Related ingredients
Frequently asked questions
- aesculus hippocastanum fruit powder hamilelikte güvenli mi?
- No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder emzirirken güvenli mi?
- Same rationale as pregnancy: no harmonised reproductive/CMR classification or EU ban/restriction found; EMA/NCCIH note insufficient data and advise caution. Maternal topical exposure could lead to low but measurable systemic exposure; no infant‑specific toxicity data were found. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder bebek cildi için güvenli mi?
- No evidence of intrinsic reproductive or developmental toxicity to infants from topical exposure to cosmetic‑grade horse‑chestnut extract. Because baby skin (0–3 yr) has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (topical adult e=1 → baby e=2). Reports flag contact dermatitis cases but not systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18503457/?utm_source=openai))
- VeriMom aesculus hippocastanum fruit powder nasıl puanlıyor?
- VeriMom aesculus hippocastanum fruit powder'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte aesculus hippocastanum fruit powder yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.